Ronald B. Prussick, MD, FRCPC

Dr. Prussick sees patients at The Washington Dermatology Center (Rockville and Frederick locations), where he has assembled the latest in technology and products for specialized medical and cosmetic dermatological care.

A Clinical Associate Professor of Dermatology at George Washington University, Dr. Prussick has been published many times, and he frequently speaks at medical conferences around the country and internationally. He has served a variety of community organizations by volunteering as a committee member, such as the Chairman of the Adverse Drug Reactions Sub-Committee at Suburban Hospital.

Dr. Prussick has been voted one of the top doctors by the Washingtonian Magazine time after time and has been repeatedly named one of America’s Top Physicians by the Consumers Research Council. Board-certified by the American Board of Dermatology in 1991, he received extensive training in the specialization of laser treatments as well as the treatment for psoriasis.

Academic appointments of Dr. Prussick, a Fellow of the American Academy of Dermatology, include:

Completed fellowship, and clinical consultant for the Dermatology Branch of the National Cancer Institute, National Institutes of Health.
Clinical Associate Professor of Dermatology, George Washington University School of Medicine.
Clinical Instructor, Division of Dermatology & Pharmacology, Dept. of Medicine, University of Toronto (1992 – 1995).
Studied medicine at McGill University in Montreal, Canada.
Dr. Prussick has served as an advisory board member or speaker for companies including AbbVie, Allergan, Amgen, Biogen/Idec, Genentech, Janssen, Leo Pharma, Medicis/Valeant, Merk, L’Oreal, Medimetriks and has worked in the capacity of cosmetic trainer for Allergan and Medicis/Valeant.

He has served on the Medical Board for the National Psoriasis Foundation and helped create the Elasense Skin Care line for Immunotec, Inc .

He has also been a Clinical researcher for Novartis, Genentech, Gene Logic Corporation, Galderma, Dow Pharmaceuticals, Astra Pharma, Amgen, and 3M.